ARCHIVES

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

This article is from The Cancer Letter archive.

Vol. 22 No. 47 | December 6, 1996

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Funding Opportunities Listed.

January 14, 2005

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998